J 5 THR 8 -11.724 -11.295
J 6 THR 10 -12.185 -11.934
J 7 VAL 14 -13.075 -13.182
J 8 ALA 7 -12.474 -11.845
J 9 PHE 24 -12.151 -13.514
J 10 ASP 9 -9.627 -9.555
J 11 VAL 36 -11.478 -14.298
J 12 ARG 8 -7.965 -7.969
J 13 PRO 16 -5.603 -6.799
J 14 GLY 9 -1.959 -2.768 <=B
J 15 GLY 1 -5.438 -4.928
J 16 VAL 7 -6.691 -6.727
J 17 VAL 7 -10.141 -9.780
J 18 HIS 18 -11.465 -12.217
J 19 SER 14 -15.057 -14.936
J 20 PHE 24 -16.367 -17.245
J 21 SER 14 -16.086 -15.847
J 22 HIS 19 -14.824 -15.304
J 23 ASN 0 -13.409 -11.867
J 31 THR 7 -15.887 -14.865
J 32 CYS 29 -19.738 -20.803
J 33 MET 16 -18.663 -18.357
J 34 PHE 33 -19.727 -21.253
J 35 THR 12 -16.927 -16.360
J 36 TYR 36 -15.623 -17.967
J 37 ALA 9 -11.074 -10.835
J 38 SER 32 -9.835 -12.384
J 39 GLN 4 -3.798 -3.821
J 40 GLY 23 -3.220 -5.495
J 41 GLY 2 -0.451 -0.629 <=B
J 42 THR 9 -1.884 -2.702 <=B
J 43 ASN 9 -4.463 -4.985
J 44 GLU 30 -7.130 -9.760
J 45 GLN 5 -8.381 -7.993
J 46 TRP 42 -13.234 -16.542
J 47 GLN 16 -15.158 -15.255
J 48 MET 23 -17.702 -18.311
J 49 SER 11 -16.464 -15.835
J 50 LEU 21 -16.630 -17.132
J 51 GLY 11 -14.551 -14.143
J 52 THR 10 -12.133 -11.888
J 53 SER 13 -9.608 -9.998
J 54 GLU 0 -5.377 -4.759
J 55 ASP 6 -3.663 -3.932
J 56 HIS 0 -6.758 -5.981
J 57 GLN 2 -8.016 -7.324
J 58 HIS 13 -11.702 -11.851
J 59 PHE 22 -15.936 -16.633
J 60 THR 15 -17.987 -17.643
J 61 CYS 32 -20.923 -22.196
J 62 THR 17 -19.208 -18.954
J 63 ILE 33 -19.084 -20.685
J 64 TRP 29 -16.294 -17.755
J 65 ARG 29 -13.112 -14.939
J 66 PRO 13 -9.427 -9.838
J 67 GLN 12 -5.260 -6.035
J 68 GLY 8 -7.947 -7.953
J 69 LYS 6 -7.573 -7.393
J 70 SER 39 -9.144 -12.578
J 71 TYR 6 -5.151 -5.248
J 72 LEU 31 -8.410 -11.008
J 73 TYR 7 -8.865 -8.650
J 74 PHE 37 -12.193 -15.046
J 75 THR 11 -10.334 -10.410
J 76 GLN 14 -13.124 -13.225
J 77 PHE 39 -17.248 -19.750
J 78 LYS 16 -19.142 -18.781
J 79 ALA 35 -21.202 -22.788
J 80 GLU 13 -20.178 -19.353
J 81 VAL 30 -19.374 -20.596
J 82 ARG 10 -15.855 -15.182
J 83 GLY 14 -12.276 -12.474
J 84 ALA 31 -13.807 -15.784
J 85 GLU 4 -13.477 -12.387
J 86 ILE 23 -16.318 -17.086
J 87 GLU 14 -14.757 -14.670
J 88 TYR 11 -16.532 -15.896
J 89 ALA 32 -19.980 -21.363
J 90 MET 14 -19.225 -18.624
J 91 ALA 29 -18.876 -20.040
J 92 TYR 24 -15.285 -16.287
J 93 SER 13 -13.500 -13.442
J 94 LYS 9 -10.617 -10.431
J 95 ALA 22 -13.241 -14.249
J 96 ALA 6 -10.755 -10.208
J 97 PHE 16 -5.678 -6.865
J 98 GLU 3 -2.304 -2.384 <=B
J 99 ARG 0 0.434 0.384 <=B
J 100 GLU 16 -2.395 -3.960
J 101 SER 3 -5.476 -5.191
J 102 ASP 12 -11.804 -11.826
J 103 VAL 16 -10.197 -10.864
J 104 PRO 11 -13.257 -12.997
J 105 LEU 31 -13.408 -15.431
J 106 LYS 9 -10.369 -10.212
J 107 THR 1 -11.924 -10.668
J 108 GLU 3 -10.333 -9.490
J 109 GLU 24 -13.116 -14.368
J 110 PHE 33 -16.364 -18.277
J 111 GLU 12 -16.838 -16.281
J 112 VAL 17 -17.797 -17.705
J 113 THR 11 -15.903 -15.339
J 114 LYS 2 -13.496 -12.174
J 115 THR 8 -16.813 -15.799
J 116 ALA 15 -20.232 -19.631
J 117 VAL 30 -20.644 -21.720
J 118 ALA 17 -18.633 -18.445
J 119 HIS 21 -15.575 -16.199
J 120 ARG 15 -12.930 -13.168
J 121 PRO 0 -8.669 -7.672
J 122 GLY 0 -6.550 -5.797
J 123 ALA 11 -8.146 -8.475
J 124 PHE 27 -11.035 -12.871
J 125 LYS 15 -7.542 -8.399
J 126 ALA 11 -10.642 -10.683
J 127 GLU 15 -11.255 -11.686
J 128 LEU 41 -15.448 -18.387
J 129 SER 18 -15.178 -15.503
J 130 LYS 24 -17.399 -18.158
J 131 LEU 39 -20.253 -22.409
J 132 VAL 16 -20.304 -19.809
J 133 ILE 36 -21.416 -23.093
J 134 VAL 9 -18.523 -17.428
J 135 ALA 29 -17.160 -18.522
J 136 LYS 5 -12.640 -11.762
J 137 ALA 9 -10.887 -10.670

Identified 5 B-Cell epitope residues out of 126 total residues